Category: General

Following a big week of half-yearly reports on the ASX, the guys cover six of their favourite stocks — and all in under 40 minutes! Stocks covered: Appen (ASX:APX), MNF Group (ASX:MNF), Nanosonics (ASX:NAN), A2 Milk (ASX:A2M), Webjet (ASX:WEB) & ProMedicus (ASX:PME).

This week, Claude & Andrew talk about the phenomenon that is Altium, why Claude continues to build a stake in 1300 Smiles and those stocks that are feeling the pinch from a slowdown in Aussie property (Bingo, Amalgamated Holdings and McGrath, among others).

This week, we discuss Paragon’s (ASX:PGC) profit downgrade, Nearmap’s (ASX:NEA) stellar performance and why Kip McGrath (ASX:KME) is Claude’s second largest position. Plus, Matt takes us through how he likes to prepare for earnings season, and why it matters.

This company is the world leader in its chosen field, with daylight between it and its nearest competitor. Moreover, the industry itself is growing rapidly and the company in question has so far only captured less than 20% of the addressable market. Sales have been growing at a double-digit rate, …

In this episode we talk through the Banking Royal Commission, and what that might mean for banks. We also review the quarterly updates for Catapult (CAT) and Envirosuite (EVS), and Matt outlines a huge challenge facing the worlds second largest economy, and what that might mean for Australia.

In this episode we talk through the quarterly updates for Dicker Data (DDR), Locality Planning (LPE), Volpara (VHT) and Audinate (AD8). Plus, we open the mailbag to answer some listener questions.

January 2019 Although the start of a new calendar year doesn’t really hold any special significance for investors, the relative dearth of corporate news makes it as good a time as any to reflect on your investments. And, if necessary, undertake a bit of course-correction. The fact is, no mater how carefully you build your portfolio, it will inexorably evolve […]

Andrew takes a bearish stance towards property, Matt walks us through his decision to sell Class (ASX:CL1) and Claude pitches the bull case for Webjet (ASX:WEB)

Andrew pitches Integrated Research (ASX:IRI), Claude makes the case for Xref (ASX:XF1), and we answer some questions from listeners.